Journal
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Volume 44, Issue 2, Pages 127-133Publisher
AMER THORACIC SOC
DOI: 10.1165/rcmb.2010-0027TR
Keywords
asthma; TGF-beta; airway remodeling; eosinophils; severe asthma
Funding
- Canadian Institutes of Health research (Ottawa, Ontario, Canada)
- J. T. Costello Memorial Research Fund (Montreal, Quebec, Canada)
- GlaxoSmithKline
- Amgen
- Canadian Institutes of Health Research
Ask authors/readers for more resources
TGF-beta is one of the main mediators involved in tissue remodeling in the asthmatic lung. This profibrotic cytokine is produced by a number of cells, including macrophages, epithelial cells, fibroblasts, and eosinophils. High expression of TGF-beta in patients with asthma was reported by many investigators. However, controversy remains whether the concentration of TGF-beta correlates with disease severity. TGF-beta is believed to play an important role in most of the cellular biological processes leading to airway remodeling. It was shown to be involved in epithelial changes, subepithelial fibrosis, airway smooth muscle remodeling, and microvascular changes. Here, sources of TGF-beta, as well as its role in the development of airway remodeling, will be reviewed. Therapeutic strategies that modulate TGF-beta will also be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available